| Jessica Rochelle Lansky, | |
|
1 Clara Maass Dr, Belleville, NJ 07109-3550 | |
| (973) 450-2100 | |
| Not Available |
| Full Name | Jessica Rochelle Lansky |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 7 Years |
| Location | 1 Clara Maass Dr, Belleville, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134631823 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 021562 (New York) | Secondary |
| 363A00000X | Physician Assistant | 25MP00454000 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rwjbh Emergency Medicine Associates, Llc | 0941612840 | 613 |
News Archive
While e-cigarette use is increasing worldwide, little is known about the health effects e-cigarettes pose for users. A University of Louisville researcher is working to change that status.
When an insurance company refused to cover Deborah Gustlin's son because he has Asperger's syndrome, she took a drastic step 'I decided to lie,' says the 51-year-old resident of Morgan Hill, Calif.
Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.
ArtVentive Medical Group, Inc. announced today that the Company has frozen its Endoluminal Occlusion device design for the peripheral category of indications in preparation for the Company's regulatory phase, prior to commercialization in Europe and North America and subsequent to venturing forward into Eastern Europe, Japan, Asia Pacific and Latin America.
Most cancers are caused by a large variety of factors that vary from one person to another. To unravel this complexity, genes that contribute to the development of a respective cancer must be identified. Such genes are called oncogenes. A good example of an oncogene is CDK8: Cyclin-dependent kinase 8.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Rochelle Lansky, 3 Century Dr, Parsippany, NJ 07054-4610 Ph: (973) 740-0607 | Jessica Rochelle Lansky, 1 Clara Maass Dr, Belleville, NJ 07109-3550 Ph: (973) 450-2100 |
News Archive
While e-cigarette use is increasing worldwide, little is known about the health effects e-cigarettes pose for users. A University of Louisville researcher is working to change that status.
When an insurance company refused to cover Deborah Gustlin's son because he has Asperger's syndrome, she took a drastic step 'I decided to lie,' says the 51-year-old resident of Morgan Hill, Calif.
Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.
ArtVentive Medical Group, Inc. announced today that the Company has frozen its Endoluminal Occlusion device design for the peripheral category of indications in preparation for the Company's regulatory phase, prior to commercialization in Europe and North America and subsequent to venturing forward into Eastern Europe, Japan, Asia Pacific and Latin America.
Most cancers are caused by a large variety of factors that vary from one person to another. To unravel this complexity, genes that contribute to the development of a respective cancer must be identified. Such genes are called oncogenes. A good example of an oncogene is CDK8: Cyclin-dependent kinase 8.
› Verified 7 days ago
Miss Lucknie Ovincy, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 50 Newark Ave, Belleville, NJ 07109 Phone: 973-751-2060 | |
Jurga Marshall, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 1 Clara Maass Dr, Clara Maass Medical Center, Belleville, NJ 07109 Phone: 973-450-2000 | |
Lellas Alhallak, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1 Clara Maass Dr, Belleville, NJ 07109 Phone: 973-450-2000 | |
James Pormentilla, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Clara Maass Dr, Clara Maass Medical Center, Belleville, NJ 07109 Phone: 973-450-2000 Fax: 973-251-1109 | |
Alexandria Mary Zummo, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Clara Maass Dr, Belleville, NJ 07109 Phone: 973-450-2000 | |
Daniela Villaman, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 36 Newark Ave Ste 132, Belleville, NJ 07109 Phone: 973-844-4161 |